A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder

This study has been completed.

Study NCT00299715 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: March 3, 2006 Last Updated: November 12, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2007
Primary Completion Date:	June 2007 (Final data collection date for primary outcome measure)